Non-Invasive Treatment to Improve Motor Function for Parkinson’s Disease
JHU REF: C13031
Invention Novelty: A minimally invasive method and device for symptom management and treatment of early stage Parkinson's disease (PD) using transcranial direct current stimulation (tDCS).
Value Proposition:
Current treatments for PD have known issues associated with their use including their high cost, side effects and diminishing efficacy over time. One method for treatment is deep brain stimulation which carries significant surgical risks and costs. Transcranial direct current stimulation (tDCS) offers a low-cost, minimally invasive approach to brain stimulation that allows patients to remain on their current medications. Additional benefits include:
- Improved motor performance post-treatment
- Effective in patients in conjunction with medication and as a stand-alone therapy
- Non-invasive approach
Technical Details:
Johns Hopkins researchers have identified an approach using tDCS to improve the effectiveness of current treatments. tDCS is a non-invasive procedure in which direct current is passed through electrodes placed on the head and localized using MRI, transcranial magnetic stimulation (TMS), or EEG. The inventors have identified a novel protocol for administering tDCS to patients that allows patients to remain on their current medication with demonstrated efficacy in improving motor symptoms over drug alone.
Looking for Partners: To develop and commercialize the technology as a method and device in the application of tDCS to those with Parkinson’s disease and other neuromuscular disorders.
Stage of Development: Prototype
Data Availability: Prototype, Clinical Study
Patent Status: Pending
Publication(s)/Associated Cases: Not at this time
